GlassScriptPhysician profile
Jessica Diggs
NPI 1295989937
$713.82
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $229 · 2023: $462 · 2024: $23.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $485.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $156.99 | 2022-2023 | Mounjaro |
| Novo Nordisk INC | $96.71 | 2022-2023 | Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.42 | 2022-2023 | Tradjenta, Synjardy |
| Dexcom, INC. | $66.70 | 2023-2024 | Dexcom G6 Transmitter |
| Pfizer INC. | $66.44 | 2022-2023 | |
| Shield Therapeutics INC | $61.11 | 2023 | Accrufer |
| Exact Sciences Corporation | $44.71 | 2023 | Cologuard Collection Kit |
| Nevro Corp. | $22.54 | 2023 | Senza |
| Vivus LLC | $21.05 | 2023 | Qsymia |
| Biohaven Pharmaceutical Holding Company LTD. | $18.99 | 2022 | |
| Glaxosmithkline, LLC. | $18.79 | 2023 | Shingrix |
| Horizon Therapeutics Plc | $17.39 | 2023 | Krystexxa |
| Astrazeneca Pharmaceuticals LP | $15.30 | 2023 | Farxiga |
| Echosens North America, INC. | $14.71 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Diggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.